4-1BB (CD137) differentially regulates murine in vivo protein- and polysaccharide-specific immunoglobulin isotype responses to Streptococcus pneumoniae

Infection and Immunity

Volumn 71, Issue 1, 2003, Pages 196-204

  Wu, Zheng Qi ^a,d   Khan, Abdul Q ^a   Shen, Yi ^a   Wolcott, Karen M ^a   Dawicki, Wojciech ^b   Watts, Tania H ^b   Mittler, Robert S ^c   Snapper, Clifford M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c EMORY UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL POLYSACCHARIDE; CD137 ANTIGEN; CD28 ANTIGEN; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHORYLCHOLINE; PNEUMOCOCCAL SURFACE PROTEIN A; T LYMPHOCYTE RECEPTOR; TEICHOIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; FEMALE; HUMORAL IMMUNITY; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; REGULATORY MECHANISM; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE ACTIVATION;

4-1BB LIGAND; ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTIGENS, CD137; BACTERIAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION; IMMUNIZATION; IMMUNOGLOBULIN ISOTYPES; LIGANDS; MICE; MICE, INBRED C57BL; PHOSPHORYLCHOLINE; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; STREPTOCOCCUS PNEUMONIAE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037223114     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.1.196-204.2003     Document Type: Article

References (37)

1. Arase, H., N. Arase, and T. Saito. 1995. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181:1235-1238.
2. Avery, O. T., C. M. MacLeod, and M. McCarty. 1944. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a deoxyribonucleic acid fraction isolated from pneumococcus type III. J. Exp. Med. 79:137-145.
3. Bertram, E. M., P. Lau, and T. H. Watts. 2002. Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection. J. Immunol. 168:3777-3785.
4. Blazar, B. R., B. S. Kwon, A. Panoskaltsis-Mortari, K. B. Kwak, J. J. Peschon, and P. A. Taylor. 2001. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients. J. Immunol. 166:3174-3183.
5. - T cells. J. Immunol. 158:3081-3089.
6. Clark, E. A. 1997. Regulation of B lymphocytes by dendritic cells. J. Exp. Med. 185:801-803.
7. Colino, J., Y. Shen, and C. M. Snapper. 2002. Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms. J. Exp. Med. 195:1-13.
8. Coyle, A. J., and J. C. Gutierrez-Ramos. 2001. The expanding B7 superfamily increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2:203-209.
9. DeBenedette, M. A., A. Shahinian, T. W. Mak, and T. H. Watts. 1997. Costimuiation of CD28-T lymphocytes by 4-1BB ligand. J. Immunol. 158:551-559.
10. DeBenedette, M. A., T. Wen, M. F. Bachmann, P. S. Ohashi, B. H. Barber, K. L. Stocking, J. J. Peschon, and T. H. Watts. 1999. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J. Immunol. 163:4833-4841.
11. Diehl, L., G. J. D. van Mierlo, A. T. den Boer, E. van der Voort, M. Fransen, L. van Bostelen, P. Krimpenfort, C. J. M. Melief, R. Mittler, R. E. M. Toes, and R. Offringa. 2002. In vivo triggering through 4-1BB enables Th-independent priming of CTL in the presence of an intact CD28 costimulatory pathway. J. Immunol. 168:3755-3762.
12. Goodwin, R. G., W. S. Din, T. Davis-Smith, D. M. Anderson, S. D. Gimpel, T. A. Sato, C. R. Maliszewski, C. I. Brannan, N. G. Copeland, N. A. Jenkins, et al. 1993. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: A member of an emerging family of cytokines with homology to tumor necrosis factor. Eur. J. Immunol. 23:2631-2641.
13. Gray, J. D., M. Hirokawa, K. Ohtsuka, and D. A. Horwitz. 1998. Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-β: Contrasting effects of anti-CD2 and anti-CD3. J. Immunol. 160:2248-2254.
14. Hatchcock, K. S., G. Laszlo, H. B. Dickler, J. Bradshaw, P. Linsley, and R. J. Hodes. 1993. Identificaion of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262:905-907.
15. Hurtado, J. C., S. H. Kim, K. E. Pollok, Z. H. Lee, and B. S. Kwon. 1995. Potential role of 4-1BB in T cell activation: Comparison with the costimulatory molecule CD28. J. Immunol. 155:3360-3367.
16. Khan, A. Q., Y. Shen, Z. Q. Wu, T. A. Wynn, and C. M. Snapper. 2002. Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. Infect. Immun. 70:749-761.
17. Kwon, B. S., J. C. Hurtado, Z. H. Lee, K. B. Kwack, S. K. Seo, B. K. Choi, B. H. Koller, G. Wolisi, H. E. Broxmeyer, and D. S. Vinay. 2002. Immune responses in 4-1Bb (CD137)-deficient mice. J. Immunol. 168:5483-5490.
18. Langstein, J., J. Michel, J. Fritsche, M. Kreutz, R. Andreesen, and H. Schwarz. 1998. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bidirectioinal signaling. J. Immunol. 160:2488-2494.
19. Melero, I., W. W. Shuford, S. A. Newby, A. Aruffo, J. A. Ledbetter, K. E. Hellstrom, R. S. Mittler, and L. Chen. 1997. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med. 3:682-685.
20. Melero, I., J. V. Johnston, W. W. Shufford, R. S. Mittler, and L. Chen. 1998. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Cell. Immunol. 190:167-172.
21. Mittler, R., T. Bailey, K. Klussman, M. Trailsmith, and M. Hoffmann. 1999. Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy. J. Exp. Med. 190:1535-1540.
22. a.National Institutes of Health, Department of Health, Education, and Welfare. 1996. Guide for the Care and Use of Laboratory Animals. Standard 78-23. Institute of Animal Resources, National Research Council, Washington, D.C.
23. Pollok, K. E., Y.-J. Kim, Z. Zhou, J. Hurtado, K. K. Kim, R. T. Pickard, and B. S. Kwon. 1993. Inducible T cell antigen 4-1BB. Analysis of expression and function. J. Immunol. 150:771-781.
24. Pollok, K. E., Y.-J. Kim, J. Hurtado, Z. Zhou, K. K. Kim, and B. S. Kwon. 1994. 4-1BB T-cell antigen binds to mature B cells and macrophage, and costimulates anti-μ-primed splenic B cells. Eur. J. Immunol. 24:367-374.
25. Razi-Wolf, Z., F. Galvin, G. Gray, and H. Reiser. 1993. Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor. Proc. Natl. Acad. Sci. USA 90:11182-11186.
26. Rothstein, T. L., J. K. M. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S. Ju, and A. Marshak-Rothstein. 1995. Protection against fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:163-165.
27. Saoulli, K., S. Y. Lee, J. L. Cannons, W. C. Yeh, A. Santana, M. D. Goldstein, N. Bangia, M. A. DeBenedette, T. W. Mak, Y. Choi, and T. H. Watts. 1998. CD28-independent TRAF2-dependent costimulation of resting T cells by 4-1BB ligand. J. Exp. Med. 187:1849-1862.
28. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186:47-55.
29. Snapper, C. M., and W. E. Paul. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944-947.
30. Snapper, C. M., T. M. McIntyre, R. Mandler, L. M. T. Peçanha, F. D. Finkelman, A. Lees, and J. J. Mond. 1992. Induction of IgG3 secretion by interferon γ: A model for T cell-independent class switching in response to T cell-independent type 2 antigens. J. Exp. Med. 175:1367-1371.
31. Snapper, C. M., Y. Shen, A. Q. Khan, J. Colino, P. Zelazowski, J. J. Mond, W. C. Gause, and Z.-Q. Wu. 2001. Distinct types of T-cell help for the induction of a humoral immune response to Streptococcus pneumoniae. Trends Immunol. 22:308-311.
32. Tan, J., J. Whitmire, Ahmed, R., T. Pearson, and C. Larsen. 1999. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J. Immunol. 163:4859-4868.
33. Tan, J. T., J. K. Whitmire, K. Murali-Krishna, R. Ahmed, J. D. Altman, R. S. Mittler, A. Sette, T. C. Pearson, and C. P. Larsen. 2000. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. J. Immunol. 164:2320-2325.
34. Wilcox, R. A., A. I. Chapoval, K. S. Gorski, M. Otsuji, T. Hin, D. B. Flies, K. Tamada, R. S. Mittler, H. Tsuchiya, D. M. Pardoll, and L. Chen. 2002. Expression of functional CD137 receptor by dendritic cells. J. Immunol. 168:4262-4267.
35. Wu, Z.-Q., Q. Vos, Y. Shen, A. Lees, S. R. Wilson, D. E. Briles, W. C. Gause, J. J. Mond, and C. M. Snapper. 1999. In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions. J. Immunol. 163:659-667.
36. Wu, Z. Q., A. Q. Khan, Y. Shen, J. Schartman, R. Peach, A. Lees, J. J. Mond, W. C. Gause, and C. M. Snapper. 2000. B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae. J. Immunol. 165:6840-6848.
37. Wu, Z.-Q., Y. Shen, A. Q. Khan, C.-L. Chu, R. Riese, H. A. Chapman, O. Kanagawa, and C. M. Snapper. 2002. The mechanism underlying T cell help for induction of an antigen-specific in vivo humoral immune response to intact Streptococcus pneumoniae is dependent on the type of antigen. J. Immunol. 168:5551-5557.